A Test for Blood Enzymes Could Predict Your Risk of Stroke Recurrence
The C-Reactive Protein (CRP) enzyme is a key indicator of increased risk of a recurrent stroke. A simple blood test can discover the levels of this enzyme, creating a potential for a cheap and non-invasive method of assessing the risk of a second stroke in patients who have already survived one ischemic stroke.
Researchers at the University of Virginia School of Medicine are looking at how a patient’s genes can affect the levels of biomarkers found in their blood. Doctors use biomarkers such as CRP in many tests for other diseases, and they could soon be part of a standard test for second stroke risk.
During the genetic studies, Dr. Stephen Williams and his research team found that a specific genetic susceptibility increased the CRP and the risk of a stroke. Using this information, the team was able to create a “hazard ratio” which gives a numeric value to a patient’s risk of suffering a second stroke based on his genetics and amount of CRP.
The medical community has been looking for an accurate method of predicting stroke risk in order to reduce the risk before one can occur. For ischemic strokes, caused by blockages interrupting blood flow to the brain, being able to treat blockages as they are just forming could save countless lives.
Suffering Even One Stroke Can Lead to Disability
Strokes do more than cause damage the heart and circulatory system. They often leave survivors with cognitive impairments and an inability to control fine motor skills. If you or a loved one are now unable to work after suffering a stroke, you may qualify for Social Security disability benefits.
The Disability Help Group’s disability advocates are waiting to assist you with filing a claim for benefits or appealing a denial of your claim. Contact us online or call us at 800-800-2009 to schedule a free consultation.